161 related articles for article (PubMed ID: 36387854)
1. Prognostic model for the exemption of adjuvant chemotherapy in stage IIIC endometrial cancer patients.
Yang XL; Yang FL; Kou LN; Wu DJ; Xie C
Front Endocrinol (Lausanne); 2022; 13():989063. PubMed ID: 36387854
[TBL] [Abstract][Full Text] [Related]
2. Construction and validation of a prognostic model for stage IIIC endometrial cancer patients after surgery.
Yang XL; Huang H; Kou LN; Lai H; Chen XP; Wu DJ
Eur J Surg Oncol; 2022 May; 48(5):1173-1180. PubMed ID: 34972620
[TBL] [Abstract][Full Text] [Related]
3. A population-based risk scoring system to individualize adjuvant treatment for stage IIIC endometrial cancer patients after surgery.
Yang XL; Zhang YE; Kou LN; Yang FL; Wu DJ
Eur J Surg Oncol; 2023 Feb; 49(2):475-480. PubMed ID: 36114049
[TBL] [Abstract][Full Text] [Related]
4. Prognostic nomogram for predicting survival in patients with high grade endometrial stromal sarcoma: a Surveillance Epidemiology, and End Results database analysis.
Wu J; Zhang H; Li L; Hu M; Chen L; Wu S; Xu B; Song Q
Int J Gynecol Cancer; 2020 Oct; 30(10):1520-1527. PubMed ID: 32839227
[TBL] [Abstract][Full Text] [Related]
5. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
[TBL] [Abstract][Full Text] [Related]
7. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy.
Bakkum-Gamez JN; Mariani A; Dowdy SC; Weaver AL; McGree ME; Martin JR; Keeney GL; Jatoi A; Gostout BS; Podratz KC
Gynecol Oncol; 2014 Mar; 132(3):578-84. PubMed ID: 24434057
[TBL] [Abstract][Full Text] [Related]
9. Subdivision of IIIC Stage for Endometrioid Carcinoma to Better Predict Prognosis and Treatment Guidance.
Wen L; Zhang Y; Chen S; Wang J; Hu W; Zhong G
Front Oncol; 2020; 10():1175. PubMed ID: 32850338
[No Abstract] [Full Text] [Related]
10. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis.
Wu J; Zhang H; Li L; Hu M; Chen L; Xu B; Song Q
Cancer Commun (Lond); 2020 Jul; 40(7):301-312. PubMed ID: 32558385
[TBL] [Abstract][Full Text] [Related]
11. Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer.
Che K; Liu F; Wu N; Liu Q; Yuan L; Wei J
Cancer Med; 2020 Oct; 9(19):7137-7150. PubMed ID: 32810384
[TBL] [Abstract][Full Text] [Related]
12. SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter study.
Kahramanoglu I; Meydanli MM; Taranenka S; Ayhan A; Salman C; Sanci M; Demirkiran F; Ortac F; Haidopoulos D; Sukhin V; Kaidarova D; Stepanyan A; Farazaneh F; Aliyev S; Ulrikh E; Kurdiani D; Yalcin İ; Mavrichev S; Akilli H; Sarı ME; Pletnev A; Aslan K; Bese T; Kairbayev M; Vlachos D; Gultekin M
Int J Gynecol Cancer; 2019 Oct; 29(8):1271-1279. PubMed ID: 31481453
[TBL] [Abstract][Full Text] [Related]
13. Does Early Chemotherapy Improve Survival in Advanced Endometrial Cancer?
Boothe D; Orton A; Kim J; Poppe MM; Werner TL; Gaffney DK
Am J Clin Oncol; 2019 Nov; 42(11):813-817. PubMed ID: 31592805
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
[TBL] [Abstract][Full Text] [Related]
15. Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
Zhang Y; Hong YK; Zhuang DW; He XJ; Lin ME
Medicine (Baltimore); 2019 Nov; 98(44):e17725. PubMed ID: 31689813
[TBL] [Abstract][Full Text] [Related]
16. Utilization of adjuvant therapies and their impact on survival for women with stage IIIC endometrial adenocarcinoma.
Wong AT; Rineer J; Lee YC; Schwartz D; Safdieh J; Weiner J; Choi K; Schreiber D
Gynecol Oncol; 2016 Sep; 142(3):514-9. PubMed ID: 27421751
[TBL] [Abstract][Full Text] [Related]
17. A prognostic nomogram for stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgical resection.
Lin Y
BMC Surg; 2022 Jul; 22(1):256. PubMed ID: 35787802
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcome of Patients With High-Risk Endometrial Carcinoma After Treatment With Chemotherapy Only.
Smogeli E; Cvancarova M; Wang Y; Davidson B; Kristensen G; Lindemann K
Int J Gynecol Cancer; 2018 Nov; 28(9):1789-1795. PubMed ID: 30365455
[TBL] [Abstract][Full Text] [Related]
19. Survival nomogram for endometrial cancer with lung metastasis: A SEER database analysis.
Yan G; Li Y; Du Y; Ma X; Xie Y; Zeng X
Front Oncol; 2022; 12():978140. PubMed ID: 36276130
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
